AUTHOR=Li Qingsong , Liu Fei , Tang Yuqi , Lee Sharen , Lang Chao , Bai Lan , Xia Yunlong 

TITLE=The Distribution of Cardiovascular-Related Comorbidities in Different Adult-Onset Cancers and Related Risk Factors: Analysis of 10 Year Retrospective Data

JOURNAL=Frontiers in Cardiovascular Medicine

VOLUME=8

YEAR=2021

URL=https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2021.695454

DOI=10.3389/fcvm.2021.695454

ISSN=2297-055X

ABSTRACT=<p><bold>Introduction:</bold> Understanding the epidemiology of cardiovascular disease (CVD) related comorbidity is a key strategy for improving the outcomes of patients with cancer. Therefore, this study aimed to assess the distribution of cardiovascular comorbidities and cardiovascular risk factors (CVRF) among five cancer sites.</p><p><bold>Methods:</bold> This is a single-centered, cross-sectional study performed in Dalian, China. Between 2008 and 2018, all newly diagnosed cancer in the First Affiliated Hospital of Dalian Medical University, China were screened. Clinical data were extracted from a comprehensive electronic health record system.</p><p><bold>Results:</bold> 35861 patients with lung, colorectal, gastric, breast, and thyroid cancer were collected retrospectively. The most prevalent CVDs in descending order were hypertension (21.9%), followed by coronary heart disease (6.5%), atrial fibrillation (2.9%), and heart failure (1%). The prevalence of hypertension significantly varies between lung (21.3%), colorectal (27.3%), gastric (22.5%), breast (16.7%), and thyroid cancer (22.4%) (<italic>P</italic> &lt; 0.001). CVRF varies with cancer sites. Age, sex, total cholesterol, triglyceride, low-density lipoprotein cholesterol, systolic blood pressure, smoking, alcohol use, and diabetes mellitus (DM) are common risk factors associated with CVD at different cancer sites. The association between DM and presence of CVD was strong in breast (odds ratio [OR] = 4.472, 95% confidence interval [CI]: 3.075–6.504, <italic>P</italic> &lt; 0.001), lung (OR = 3.943; 95% CI: 3.270–4.754, <italic>P</italic> &lt; 0.001), colorectal (OR = 3.049; 95% CI: 2.326–3.996, <italic>P</italic> &lt; 0.001), and gastric (OR = 2.508; 95% CI: 1.927–3.264, <italic>P</italic> &lt; 0.001) cancer.</p><p><bold>Conclusion:</bold> Cancer patients had a significant burden of CVD and increased CVRF. The prevalence of CVRF and CVD comorbidity differ for cancer types. DM remains significantly associated with CVD at different cancer sites except for thyroid cancer.</p>